Furthermore, the use of chemotherapeutics in combination with anti-fibronectin agents on collagen-deficient ECMs enhanced cancer cells’ susceptibility to chemotherapeutics by 30 to 50% and led to a decrease in tumor invasion and a reduction in the colony formation [104]. The gene discussed is FN1; the disease is neoplasm.